In this issue:
Challenge: virtual reality-assisted therapy for verbal auditory hallucinations
Real-world clozapine augmentation with antidepressants
OPTiMiSE: extrapyramidal symptoms in first-episode schizophrenia
Paternal age, de novo mutations & schizophrenia onset
A botulinum neurotoxin clinic for clozapine-induced sialorrhea
Metacognitive training for psychosis
Real-world antipsychotic discontinuation & switching
Retinal age gap, hypertension & diabetes in schizophrenia
Brief vs. ultra-brief ECT in schizophrenia
PURPOSE: omega-3 fatty acids in youth at ultra-high risk of psychosis
Please login below to download this issue (PDF)